NZD - BEARISH
1️⃣ Investors were cautious on news that AstraZeneca paused its late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
2️⃣ Director General of Health Ashley Bloomfield reported six fresh cases of the novel coronavirus in New Zealand, all of which are linked to the Mt Roskill "mini-cluster."
3️⃣ Manufacturing sales in New Zealand plunged 12.1% year-on-year during the second quarter, posting the largest fall since the series began in 1994.
JPY - BULLISH
1️⃣ Traders sought the safety of haven assets following news that AstraZeneca paused its late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
=====
TECHNICAL
=====
- We're shorting NZDJPY on SBR level + SMA100 area on H1 chart.
- NZDJPY still in bearish zone.
1️⃣ Investors were cautious on news that AstraZeneca paused its late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
2️⃣ Director General of Health Ashley Bloomfield reported six fresh cases of the novel coronavirus in New Zealand, all of which are linked to the Mt Roskill "mini-cluster."
3️⃣ Manufacturing sales in New Zealand plunged 12.1% year-on-year during the second quarter, posting the largest fall since the series began in 1994.
JPY - BULLISH
1️⃣ Traders sought the safety of haven assets following news that AstraZeneca paused its late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
=====
TECHNICAL
=====
- We're shorting NZDJPY on SBR level + SMA100 area on H1 chart.
- NZDJPY still in bearish zone.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.